216 related articles for article (PubMed ID: 31485649)
1. MicroRNA‑155 inhibits the proliferation of CD8+ T cells via upregulating regulatory T cells in vitiligo.
Lv M; Li Z; Liu J; Lin F; Zhang Q; Li Z; Wang Y; Wang K; Xu Y
Mol Med Rep; 2019 Oct; 20(4):3617-3624. PubMed ID: 31485649
[TBL] [Abstract][Full Text] [Related]
2. Occludin Promotes Adhesion of CD8
Zou P; Xiao Y; Deng Q; Shi Y; You R; Pi Z; Liu J; Zhan Y; Zeng Q; Zeng Z; Xiao R
Oxid Med Cell Longev; 2022; 2022():6732972. PubMed ID: 35222802
[TBL] [Abstract][Full Text] [Related]
3. MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells.
Zheng Z; Sun R; Zhao HJ; Fu D; Zhong HJ; Weng XQ; Qu B; Zhao Y; Wang L; Zhao WL
Mol Cancer; 2019 Mar; 18(1):54. PubMed ID: 30925928
[TBL] [Abstract][Full Text] [Related]
4. HO-1 regulates the function of Treg: Association with the immune intolerance in vitiligo.
Zhang Q; Cui T; Chang Y; Zhang W; Li S; He Y; Li B; Liu L; Wang G; Gao T; Li C; Jian Z
J Cell Mol Med; 2018 Sep; 22(9):4335-4343. PubMed ID: 29974998
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells from active non-segmental vitiligo exhibit lower suppressive ability on CD8+CLA+ T cells.
Lin M; Zhang BX; Shen N; Dong XJ; Zhang C; Qi XY; Zhu J; Li YZ; Man MQ; Tu CX
Eur J Dermatol; 2014; 24(6):676-82. PubMed ID: 25335433
[TBL] [Abstract][Full Text] [Related]
6. Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo.
Lili Y; Yi W; Ji Y; Yue S; Weimin S; Ming L
PLoS One; 2012; 7(5):e37513. PubMed ID: 22649532
[TBL] [Abstract][Full Text] [Related]
7. Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo.
Wańkowicz-Kalińska A; van den Wijngaard RM; Tigges BJ; Westerhof W; Ogg GS; Cerundolo V; Storkus WJ; Das PK
Lab Invest; 2003 May; 83(5):683-95. PubMed ID: 12746478
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress-induced IL-15 trans-presentation in keratinocytes contributes to CD8
Chen X; Guo W; Chang Y; Chen J; Kang P; Yi X; Cui T; Guo S; Xiao Q; Jian Z; Li K; Gao T; Li S; Liu L; Li C
Free Radic Biol Med; 2019 Aug; 139():80-91. PubMed ID: 31078730
[TBL] [Abstract][Full Text] [Related]
9. MIF inhibition alleviates vitiligo progression by suppressing CD8
Chen J; Guo W; Du P; Cui T; Yang Y; Wang Y; Kang P; Zhang Z; Wang Q; Ye Z; Liu L; Jian Z; Gao T; Bian H; Li S; Li C
J Pathol; 2023 May; 260(1):84-96. PubMed ID: 36852981
[TBL] [Abstract][Full Text] [Related]
10. Assessment of tissue FoxP3+, CD4+ and CD8+ T-cells in active and stable nonsegmental vitiligo.
Abdallah M; Lotfi R; Othman W; Galal R
Int J Dermatol; 2014 Aug; 53(8):940-6. PubMed ID: 24527781
[TBL] [Abstract][Full Text] [Related]
11. Reduction of skin-homing cytotoxic T cells (CD8+ -CLA+) in patients with vitiligo.
Antelo DP; Filgueira AL; Cunha JM
Photodermatol Photoimmunol Photomed; 2011 Feb; 27(1):40-4. PubMed ID: 21198882
[TBL] [Abstract][Full Text] [Related]
12. Dermal mesenchymal stem cells (DMSCs) inhibit skin-homing CD8+ T cell activity, a determining factor of vitiligo patients' autologous melanocytes transplantation efficiency.
Zhou MN; Zhang ZQ; Wu JL; Lin FQ; Fu LF; Wang SQ; Guan CP; Wang HL; Xu A
PLoS One; 2013; 8(4):e60254. PubMed ID: 23577097
[TBL] [Abstract][Full Text] [Related]
13. Overexpressed perforin contributes to the melanocyte destruction via epigenetic regulation in patients with vitiligo.
Deng Q; Zou P; Du P; Shi Y; Pi Z; Xiao Y; Kanekura T; Zhang H; Zhan Y; Qiu X; Ding Y; Zeng Z; Xiao R
Int Immunopharmacol; 2023 Jan; 114():109574. PubMed ID: 36538850
[TBL] [Abstract][Full Text] [Related]
14. Oxidative Stress-Induced HMGB1 Release from Melanocytes: A Paracrine Mechanism Underlying the Cutaneous Inflammation in Vitiligo.
Cui T; Zhang W; Li S; Chen X; Chang Y; Yi X; Kang P; Yang Y; Chen J; Liu L; Jian Z; Li K; Wang G; Gao T; Song P; Li C
J Invest Dermatol; 2019 Oct; 139(10):2174-2184.e4. PubMed ID: 30998983
[TBL] [Abstract][Full Text] [Related]
15. CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis.
Wu J; Zhou M; Wan Y; Xu A
Mol Med Rep; 2013 Jan; 7(1):237-41. PubMed ID: 23042234
[TBL] [Abstract][Full Text] [Related]
16. Decreased regulatory T-cells and CD4(+) /CD8(+) ratio correlate with disease onset and progression in patients with generalized vitiligo.
Dwivedi M; Laddha NC; Arora P; Marfatia YS; Begum R
Pigment Cell Melanoma Res; 2013 Jul; 26(4):586-91. PubMed ID: 23574980
[TBL] [Abstract][Full Text] [Related]
17. Th1-like Treg in vitiligo: An incompetent regulator in immune tolerance.
Chen J; Wang X; Cui T; Ni Q; Zhang Q; Zou D; He K; Wu W; Ma J; Wang Y; Guo W; Li C; Li S
J Autoimmun; 2022 Jul; 131():102859. PubMed ID: 35792518
[TBL] [Abstract][Full Text] [Related]
18. CCL22 to Activate Treg Migration and Suppress Depigmentation in Vitiligo.
Eby JM; Kang HK; Tully ST; Bindeman WE; Peiffer DS; Chatterjee S; Mehrotra S; Le Poole IC
J Invest Dermatol; 2015 Jun; 135(6):1574-1580. PubMed ID: 25634358
[TBL] [Abstract][Full Text] [Related]
19. Melanocyte-specific CD8+ T cells are associated with epidermal depigmentation in a novel mouse model of vitiligo.
You S; Cho YH; Byun JS; Shin EC
Clin Exp Immunol; 2013 Oct; 174(1):38-44. PubMed ID: 23711243
[TBL] [Abstract][Full Text] [Related]
20. Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment.
Zhang S; Ke X; Zeng S; Wu M; Lou J; Wu L; Huang P; Huang L; Wang F; Pan S
Cell Mol Immunol; 2015 Sep; 12(5):580-91. PubMed ID: 26166762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
